These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37543293)

  • 21. Humoral immunity and injection-site reactions in cattle vaccinated with a multivalent clostridial vaccine administered via subcutaneous injection or via transdermal needle-free injection.
    Woolums AR; Ensley DT; Tanner PA; Fankhauser R; Shen J; Songer JG; Leard AT; Milward FW; Pence ME; Hurley DJ
    Am J Vet Res; 2011 Aug; 72(8):1124-9. PubMed ID: 21801072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MLST analysis reveals a highly conserved core genome among poultry isolates of Clostridium septicum.
    Neumann AP; Rehberger TG
    Anaerobe; 2009 Jun; 15(3):99-106. PubMed ID: 19402197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
    Salvarani FM; Conceição FR; Cunha CE; Moreira GM; Pires PS; Silva RO; Alves GG; Lobato FC
    Vaccine; 2013 Aug; 31(38):4152-5. PubMed ID: 23845812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin.
    Gao X; Ma Y; Wang Z; Bai J; Jia S; Feng B; Jiang Y; Cui W; Tang L; Li Y; Wang L; Xu Y
    Virulence; 2019 Dec; 10(1):166-179. PubMed ID: 30806148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits.
    Zhao L; Guo Z; Liu J; Wang Z; Wang R; Li Y; Wang L; Xu Y; Tang L; Qiao X
    Vaccine; 2017 Jul; 35(32):4010-4021. PubMed ID: 28625525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum.
    Hickey MJ; Kwan RY; Awad MM; Kennedy CL; Young LF; Hall P; Cordner LM; Lyras D; Emmins JJ; Rood JI
    PLoS Pathog; 2008 Apr; 4(4):e1000045. PubMed ID: 18404211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation to Clostridium septicum toxoid.
    Kennedy K
    Dev Biol Stand; 1976; 32():123-30. PubMed ID: 1001826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of turkeys with Clostridium septicum bacterin-toxoid: evaluation of protection against clostridial dermatitis.
    Thachil AJ; McComb B; Kromm M; Nagaraja KV
    Avian Dis; 2013 Jun; 57(2):214-9. PubMed ID: 24689176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low prevalence of Clostridium septicum fecal carriage in an adult population.
    Kopliku FA; Schubert AM; Mogle J; Schloss PD; Young VB; Aronoff DM
    Anaerobe; 2015 Apr; 32():34-36. PubMed ID: 25481351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alpha-toxin of Clostridium septicum is essential for virulence.
    Kennedy CL; Krejany EO; Young LF; O'Connor JR; Awad MM; Boyd RL; Emmins JJ; Lyras D; Rood JI
    Mol Microbiol; 2005 Sep; 57(5):1357-66. PubMed ID: 16102005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.
    Fathi Najafi M; Rahman Mashhadi M; Hemmaty M
    Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-toxin production by Clostridium septicum at different culture conditions.
    Cortiñas TI; Mattar MA; Stefanini de Guzmán AM
    Anaerobe; 1997; 3(2-3):199-202. PubMed ID: 16887590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
    Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
    Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for Clostridium septicum as a primary cause of cellulitis in commercial turkeys.
    Tellez G; Pumford NR; Morgan MJ; Wolfenden AD; Hargis BM
    J Vet Diagn Invest; 2009 May; 21(3):374-7. PubMed ID: 19407093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Induced expression of alpha-toxin gene of Clostridium perfringens in recombinant Lactobacillus casei and their immunoprotective in mice].
    Li X; Xia C; Li Y
    Wei Sheng Wu Xue Bao; 2009 Aug; 49(8):1115-20. PubMed ID: 19835176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
    Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
    Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and immunological characterization of an inactivated canine Clostridium perfringens type A vaccine.
    Xing J; Ji X; Sun Y; Zhu L; Jiang Q; Guo X; Liu J
    Lett Appl Microbiol; 2019 Nov; 69(5):385-390. PubMed ID: 31529707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.